• Global expansion strategy: NephroPlus targets 15% to 20% revenue CAGR over three to four years by adding 40 to 50 clinics annually in India, 10 to 15 in the Philippines, and entering a new country every 12 to 18 months.
• Saudi tender approach: The company launched a 25-bed clinic in Riyadh and formed a 51:49 joint venture with Al-Faisaliah Group to bid on government tenders, which account for 99% of dialysis treatments in Saudi Arabia.
• Philippines market dynamics: Philippines operations yield $110 per session compared to $22 in India, and the company is consolidating 18 local entities into five to reduce operational complexity.
• Internal talent supply: To mitigate nurse and technician shortages—with employee costs representing 25% of revenue—NephroPlus trains staff in its Indian and Philippine academies for domestic deployment and international expat assignments.
• India revenue mix: The domestic business derives 70% of its revenue from captive setups across 310 private hospitals and 30% from public-private partnerships, maintaining a 95% contract renewal rate.